Polymerase Chain Reaction (PCR): A Global Market Outlook Forecasts the Market to Reach US$38 Billion by 2015

01 Jun 2010 • by Natalie Aster

The report ‘Polymerase Chain Reaction (PCR): A Global Market Outlook’ reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

  • Emerging market trends
  • Advancements in the technological space
  • Market demand of the segments (by-region)
  • Key growth areas and market size
  • Key competitor’s Edge

The analysis primarily deals with three major market segments i.e., research, diagnosis and instruments. Further, the subdivided categories include:


  • DNA Sequencing
  • Forensic Science
  • DNA Cloning
  • Others


  • Infectious Diseases
  • Cancer
  • Genetic Abnormalities


  • Instrumentation
  • Reagents
  • Consumables

The period considered for the PCR market analysis is 2007-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 300 leading market players are identified and 49 key companies that project improved market activities in the near future are profiled. The report consists of 293 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry. Anticipated of protracted economic recovery towards to 2011, we have used CAGR to forecasts to 2011 till 2015.


The global PCR market is projected to reach around US$38.1 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 11.6% for the analysis period, 2007-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$8.5 billion by end-2010. Europe and Asia-Pacific together account for approximately 55% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 15.3%, to worth around US$0.8 billion in 2015. Irrespective of the economic turmoil, Japan is expected to hold the second rank among the countries holding top-PCR market share, figured to occupy 13% of the global market in 2012 with a market value of US$3.3 billion.